Key Takeaways TMDX reported Q2 EPS of $0.92, up 162.9% year over year and 91.7% above the consensus estimate.Revenue rose 37.7% to $157.4M, driven by strong OCS use, NOP expansion, and logistics service growth.Operating margin expanded to 23.2%, fueled by a 192.3% profit surge and solid expense management.TransMedics Group, Inc. (TMDX) delivered earnings per share (EPS) of 92 cents in the second quarter of 2025, which surged 162.9% year over year. The figure surpassed the Zacks Consensus Estimate by 91.7%.T ...